メタ情報
| meta description平均長 | 245.17 |
|---|
| OGPありページ数 | 20 |
|---|
| Twitterカードありページ数 | 20 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 135 |
|---|
| ページあたり内部リンク平均 | 29.5 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| Article | 1 |
| Citation | 1 |
| Publication | 1 |
| date | 1 |
| title | 0.966667 |
| CHAPTER | 0.443292 |
| Cancer | 0.401074 |
| University | 0.401074 |
| Pharmacy | 0.370205 |
| Oncology | 0.358162 |
| Hospital | 0.340254 |
| Oncol | 0.333333 |
| member | 0.295528 |
| Pharmacist | 0.28653 |
| biosimilars | 0.279388 |
| Emma | 0.266667 |
| Clinical | 0.256207 |
| Australia | 0.233333 |
| Chief | 0.233333 |
| biosimilar | 0.232806 |
| pharmacy | 0.211091 |
| Society | 0.211091 |
| was | 0.211091 |
| your | 0.206215 |
| pharmacist | 0.204966 |
| Heidelberg | 0.204966 |
| oncology | 0.20391 |
| use | 0.200948 |
| October | 0.2 |
| Clin | 0.2 |
| Pharmacists | 0.2 |
| professional | 0.2 |
| Japanese | 0.2 |
| Hoppe | 0.2 |
| Tichy | 0.2 |
| Biosimilars | 0.189982 |
| safety | 0.179345 |
| years | 0.168873 |
| his | 0.168873 |
| Randomized | 0.166667 |
| HER2 | 0.166667 |
| Biosimilar | 0.166667 |
| Center | 0.166667 |
| Japan | 0.166667 |
| knowledge | 0.163128 |
| world | 0.163128 |
| cancer | 0.161965 |
| team | 0.161173 |
| been | 0.153724 |
| completed | 0.153724 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Publication | date | 4.125813 | 120 |
| Article | title | 4.053872 | 116 |
| Only | fill | 3.976641 | 88 |
| funding | supported | 3.849683 | 80 |
| Pfizer | funding | 3.849683 | 80 |
| Inc | Pfizer | 3.849683 | 80 |
| Inc | PCM | 3.849683 | 80 |
| acting | company | 3.849683 | 80 |
| organiser | secretariat | 3.849683 | 80 |
| independently | run | 3.849683 | 80 |
| financial | independently | 3.849683 | 80 |
| financial | supporter | 3.849683 | 80 |
| had | input | 3.849683 | 80 |
| PCM | Scientific | 3.790126 | 80 |
| company | education | 3.790126 | 80 |
| organiser | programme | 3.790126 | 80 |
| input | into | 3.790126 | 80 |
| acting | scientific | 3.67908 | 80 |
| scientific | secretariat | 3.67908 | 80 |
| Scientific | medical | 3.673784 | 80 |
| education | medical | 3.673784 | 80 |
| created | faculty | 3.577299 | 80 |
| faculty | funder | 3.577299 | 80 |
| fill | you | 3.494098 | 68 |
| real | world | 3.450582 | 56 |
| funder | has | 3.438963 | 80 |
| had | has | 3.438963 | 80 |
| educational | independent | 3.412229 | 80 |
| Only | you | 3.357836 | 66 |
| Education | hub | 3.205702 | 28 |
| mini | quizzes | 3.150996 | 32 |
| not | you | 3.139568 | 48 |
| Article | date | 3.090072 | 87 |
| case | studies | 3.044108 | 28 |
| data | papers | 3.044108 | 28 |
| Pfizer | supported | 3.030583 | 60 |
| Inc | funding | 3.030583 | 60 |
| PCM | Pfizer | 3.030583 | 60 |
| acting | secretariat | 3.030583 | 60 |
| financial | run | 3.030583 | 60 |
| independently | supporter | 3.030583 | 60 |
| created | supporter | 3.030583 | 60 |
| created | funder | 3.030583 | 60 |
| funder | had | 3.030583 | 60 |
| Inc | Scientific | 2.978992 | 60 |
| acting | education | 2.978992 | 60 |
| programme | secretariat | 2.978992 | 60 |
| programme | run | 2.978992 | 60 |
| had | into | 2.978992 | 60 |
| PCM | medical | 2.929802 | 60 |